Prediction of Future Weight Change With Dopamine Transporter
NCT03146429 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2018-04-24
Summary
This is the re-analyzing study of observational study by Parkinson's Progression Markers Initiative
Conditions
- Weight Change, Body
Interventions
- DIAGNOSTIC_TEST
-
I-123 FP-CIT Single photon emission tomography
Brain scan for dopamine transporter
Sponsors & Collaborators
-
Pusan National University Hospital
lead OTHER
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2017-04-15
- Completion
- 2017-04-15
More Related Trials
-
Diagnosis of PD and PD Progression Using DWI
NCT02837172 ·Status: COMPLETED
-
Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease
NCT00153972 ·Status: COMPLETED ·Phase: PHASE4
-
[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor
NCT04265209 ·Status: COMPLETED ·Phase: PHASE3
-
Short- and Long-term Behavioral, Cognitive and Motor Outcomes of Frameless Deep Brain Stimulation in Patients With Parkinson's Disease: a Prospective Observational Study
NCT05752656 ·Status: RECRUITING
-
Predicting Cognition After DBS for Parkinson's Disease 2
NCT06272968 ·Status: ACTIVE_NOT_RECRUITING
-
A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
NCT01550484 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
FDOPA PET and Nutritional Support in Parkinson's Disease
NCT04459052 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
NCT00129181 ·Status: COMPLETED ·Phase: NA
-
A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease
NCT00117819 ·Status: COMPLETED ·Phase: PHASE2
-
[11C]Donepezil PET For Imaging The Autonomous Nervous System In Parkinsons Disease
NCT02012595 ·Status: COMPLETED
-
Short Pulse Width Versus Low Frequency DBS in Parkinson's Disease
NCT05034510 ·Status: UNKNOWN ·Phase: NA
-
DBS Imaging-based vs. Threshold Assessment-based Programming
NCT06223399 ·Status: RECRUITING ·Phase: NA
-
Motor Performance in Parkinson's Disease After High Intensive Exercise or Deep Brain Stimulation
NCT01446549 ·Status: COMPLETED ·Phase: NA
-
Body Weight Gain, Parkinson, Subthalamic Stimulation
NCT00529724 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of the Impact of Disclosing Imaging Study Information to Trial Participants
NCT00354003 ·Status: COMPLETED
-
Personality, as a Predictive Factor of Therapeutic Response on Quality of Life After Continuous Perfusion of Dopaminergic Drugs, in Parkinson's Disease
NCT03793491 ·Status: UNKNOWN
-
Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease
NCT03354455 ·Status: COMPLETED ·Phase: NA
-
Evolution of Hypodopaminergic Syndrome in Early Parkinson's Disease
NCT03141944 ·Status: COMPLETED
-
A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
NCT00382967 ·Status: COMPLETED ·Phase: PHASE4
-
Progression of Striatal and Extrastriatal Degeneration in PD and PSP Patients
NCT03840252 ·Status: COMPLETED ·Phase: NA
-
Feasibility Of Objective Measures and Outpatient Washout in Disease Modifying Trials for Parkinson's Disease
NCT06192823 ·Status: COMPLETED
-
PharmacoMRI of Parkinson Disease
NCT01528592 ·Status: COMPLETED ·Phase: NA
-
Super-resolution of Brain Magnetic Resonance Images in Deep Brain Stimulation for Parkinson's Disease
NCT05596201 ·Status: COMPLETED
-
Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
NCT00368199 ·Status: COMPLETED
-
Deep Brain Stimulation and Digestive Symptomatology
NCT00639275 ·Status: COMPLETED